Callahan Brianna N, Kammala Ananth K, Syed Meesum, Yang Canchai, Occhiuto Christopher J, Nellutla Rithvik, Chumanevich Alena P, Oskeritzian Carole A, Das Rupali, Subramanian Hariharan
Department of Physiology, Michigan State University, East Lansing, MI, United States.
Department of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, United States.
Front Immunol. 2020 Apr 24;11:703. doi: 10.3389/fimmu.2020.00703. eCollection 2020.
Mast cells are tissue-resident innate immune cells known for their prominent role in mediating allergic reactions. MAS-related G-protein coupled receptor-X2 (MRGPRX2) is a promiscuous G-protein coupled receptor (GPCR) expressed on mast cells that is activated by several ligands that share cationic and amphipathic properties. Interestingly, MRGPRX2 ligands include certain FDA-approved drugs, antimicrobial peptides, and neuropeptides. Consequently, this receptor has been implicated in causing mast cell-dependent pseudo-allergic reactions to these drugs and chronic inflammation associated with asthma, urticaria and rosacea in humans. In the current study we examined the role of osthole, a natural plant coumarin, in regulating mast cell responses when activated by the MRGPRX2 ligands, including compound 48/80, the neuropeptide substance P, and the cathelicidin LL-37. We demonstrate that osthole attenuates both the early (Ca mobilization and degranulation) and delayed events (chemokine/cytokine production) of mast cell activation via MRGPRX2 . Osthole also inhibits MrgprB2- (mouse ortholog of human MRGPRX2) dependent inflammation in mouse models of pseudo-allergy. Molecular docking analysis suggests that osthole does not compete with the MRGPRX2 ligands for interaction with the receptor, but rather regulates MRGPRX2 activation via allosteric modifications. Furthermore, flow cytometry and confocal microscopy experiments reveal that osthole reduces both surface and intracellular expression levels of MRGPRX2 in mast cells. Collectively, our data demonstrate that osthole inhibits MRGPRX2/MrgprB2-induced mast cell responses and provides a rationale for the use of this natural compound as a safer alternative treatment for pseudo-allergic reactions in humans.
肥大细胞是驻留在组织中的固有免疫细胞,以其在介导过敏反应中的突出作用而闻名。MAS相关G蛋白偶联受体X2(MRGPRX2)是一种在肥大细胞上表达的多配体G蛋白偶联受体(GPCR),可被几种具有阳离子和两亲性特性的配体激活。有趣的是,MRGPRX2配体包括某些FDA批准的药物、抗菌肽和神经肽。因此,该受体被认为与这些药物引起的肥大细胞依赖性假过敏反应以及人类哮喘、荨麻疹和酒渣鼻相关的慢性炎症有关。在本研究中,我们研究了天然植物香豆素蛇床子素在调节肥大细胞对MRGPRX2配体(包括化合物48/80、神经肽P物质和cathelicidin LL-37)激活的反应中的作用。我们证明,蛇床子素可减弱肥大细胞通过MRGPRX2激活的早期事件(钙动员和脱颗粒)和延迟事件(趋化因子/细胞因子产生)。蛇床子素还可在假过敏小鼠模型中抑制MrgprB2(人类MRGPRX2的小鼠同源物)依赖性炎症。分子对接分析表明,蛇床子素不会与MRGPRX2配体竞争与受体的相互作用,而是通过变构修饰调节MRGPRX2的激活。此外,流式细胞术和共聚焦显微镜实验表明,蛇床子素可降低肥大细胞中MRGPRX2的表面和细胞内表达水平。总的来说,我们的数据表明蛇床子素可抑制MRGPRX2/MrgprB2诱导的肥大细胞反应,并为使用这种天然化合物作为人类假过敏反应更安全的替代治疗方法提供了理论依据。